Clinical Trial Update: Hydroxyurea and Transfusion [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating hydroxyurea and transfusion for sickle cell disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Children's National Research Institute | Conditions: Sickle Cell Disease | Phase 2 | Status: COMPLETED